Author

Yong Zhang

Observed name: ZHANG Yong

Institutions: Lianyungang Oriental Hospital, Affiliated Hospital of Jiangsu University

Observed institutions: Lianyungang Oriental Hospital, Affiliated Hospital of Jiangsu University, First Affiliated Hospital of Soochow University

ORCID: 0000-0001-9435-1562

Observed ORCID: 0000-0001-9435-1562

OpenAlex ID: A5044025514

NFAT c1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL‐mediated extrinsic signaling pathway

2018 · Sanrong Xu, Penghao Shu, et al. · Cancer Medicine · 35

Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Hepatic Stellate Cell Activation and Liver Fibrosis by Upregulating MicroRNA‐455‐3p through Suppression of p21‐Activated Kinase‐2

2021 · Qing Zhou, Tengfei Gu, et al. · BioMed Research International · 21

Anti-Liver Fibrosis Role of miRNA-96-5p via Targeting FN1 and Inhibiting ECM-Receptor Interaction Pathway

2023 · Yong Zhang, Tengfei Gu, et al. · Applied Biochemistry and Biotechnology · 17

Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis by inhibiting hepatocyte ferroptosis and macrophage polarization via the miR-455-3p/PLAU axis

2025 · Yong Zhang, Jin Dou, et al. · Stem Cell Research & Therapy · 9

Integrating Bulk and Single-Cell RNA Sequencing Data Reveals the Prognostic Significance of HOXC9-Related Immune Gene Signatures in Hepatocellular Carcinoma

2025 · Yong Zhang, Hengliang Sun, et al. · OncoTargets and Therapy · 4

Association of tuberous sclerosis gene 1/2 mutations with the progression of hepatocellular carcinoma and prognosis

2021 · ZHANG Yong · DOAJ (DOAJ: Directory of Open Access Journals)

Works count: 6

Citation count: 86

H-index: 4

I10-index: 3